Have you ever heard of 1,5-Anhydroglucitol (1,5-AG)? If not get ready to learn in this week’s Homerun Slides why testing for this compound will give a more accurate scorecard on diabetes care than an A1c or finger stick could even come close to. Our Disaster Averted is an analysis of …

  With this week’s Homerun Slides series, we present the second set of a four part series which we’ll be bringing you over the course of four months. With this second set, we examine the currently available Postprandial Hyperglycemia Assessment Tools, and then explore one of the most recently discovered …

Idea Oven, LLC iOS/Free   Mediforms EMR is an Electronic Medical Records (EMR) app for the iPad. All entry is done via touches so you can capture your patient history and encounter details as quickly as (or quicker than) your traditional paper forms.

Things are in full swing at AACE this weekend and we will be bringing you the most important and usable information in next week’s newsletter.    One of the most talked-about insulin-delivery products is the V-Go insulin delivery device. Early results from the "SIMPLE" study followed patients who switched from …

Cholesterol Lowering Treatment Options (pdf)  This week, we have an exclusive new Tool for Your Practice for you prepared by our talented interns, Lauren Self, UF College of Pharmacy, and Gabrielle Soussman, LECOM College of Pharmacy, summing up in a short 6 page printout, the current and available Cholesterol Lowering …

The number of physicians participating in accountable care organizations (ACOs) has increased drastically since 2012, according to the 2013 Physician Compensation Report. Last year, just 8% of the nation’s physicians were either in an ACO or planned to be in one within the year. This year, 24% of respondents are …

Using results from the EPIC study, researchers also found that the increase in risk fell slightly after adjusting the findings to take account of BMI. This suggests it was not simply being overweight that led to the trend, they said. A total of 350,000 individuals were questioned about their diet, …

There is currently fierce competition to get SGLT2 medications approved and onto the market. The first SGLT2 drug, Invokana (canagliflozin), developed by Johnson and Johnson, was approved by the FDA just recently. Ertugliflozin, which is ready for Phase III trials, will likely be marketed as a drug taken on its …

A screening program for diabetic retinopathy diminished the likelihood of eye disease in patients with diabetes….

Teens targeting strength, cardio fitness battle insulin resistance….